-
-
-
-
-
-
-
RECORDATI SHAREHOLDERS APPROVE THE 2019 ACCOUNTS. DIVIDEND € 1.00 PER SHARE (+8.7% vs 2018)
-
-
-
-
-
-
-
RECORDATI SHAREHOLDERS APPROVE THE 2018 ACCOUNTS. DIVIDEND € 0.92 PER SHARE (+8.2% vs 2017)
-
-
-
-
-
-
-
RECORDATI ANNOUNCES SALES AND MARGIN GROWTH IN THE FIRST QUARTER 2018. REVENUES +7.2%, OPERATING INCOME +12.4%, NET INCOME +10.3%
-
-
-
-
-
-
-
RECORDATI ACQUIRES RIGHTS TO ASTRAZENECA'S METOPROLOL BASED TREATMENTS IN EUROPE
-
-
-
-
-
-
-
RECORDATI ACQUIRES THE SWISS PHARMACEUTICAL COMPANY PRO FARMA
-
-
-
-
-
-
-
Reliant Gold Announces Management and Board Changes and Grants Options
-
-
-
-
-
-
-
Iron Mountain Will Offer Undertakings to UK Competition and Markets Authority To Address Concerns Over Proposed Acquisition of Recall
-
1,157,803 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

